Originally published 2020-12-31.

In late December 2020, an emergency-room nurse in Southern California tested positive for COVID-19 eight days after receiving his first shot of the Pfizer-BioNTech vaccine. The headline spread quickly, and many readers took it as a sign that the vaccine did not work. It was nothing of the kind. A single dose had not yet had time to protect him, he had received only half of a two-dose course, and he may well have been infected before the needle ever went in.
Here is what happened, why infectious-disease specialists were not surprised, and what the case teaches about how vaccine protection builds.
What happened to the nurse
The nurse, a 45-year-old identified by San Diego station 10News only as Matthew W., worked in the emergency departments of two local hospitals. He received his first Pfizer dose on 18 December 2020. Apart from a sore arm for a day, he felt fine.
On Christmas Eve, six days after the shot and following a shift on a COVID-19 unit, he developed chills. Muscle aches and tiredness followed, peaking on Christmas Day. On 26 December he went to a drive-up hospital testing site, and the result came back positive. When he spoke to reporters he was still fatigued but recovering.
His job matters to the story. Hospital staff caring for COVID-19 patients were among the first people offered the vaccine precisely because they faced repeated, close exposure to the virus every day. That same exposure meant some of them were bound to catch it during the gap between their first injection and full protection.
Why one dose had not had time to work
A vaccine does not act like a shield that switches on the moment it is injected. It shows the immune system a harmless preview of the virus, and the body then needs time to produce antibodies and train the T cells that recognise infected cells. That process takes days to weeks.
Dr. Christian Ramers, an infectious-disease specialist with Family Health Centers of San Diego who sat on the county's vaccine advisory panel, told 10News that protection starts to develop roughly 10 to 14 days after the first dose. In his words, the nurse's infection was "exactly what we'd expect to happen if someone was exposed."
Pfizer said the same thing in its own statement on the case, noting that its phase 3 trial showed the vaccine "provides some protection against COVID-19 within about 10 days of the first dose" and that the second dose boosts it substantially. Matthew's symptoms began on day six, well before that window.
What the trial numbers actually meant
The Pfizer-BioNTech phase 3 trial gave two injections 21 days apart. Between the first and second dose, efficacy against symptomatic COVID-19 was about 52%. From seven days after the second dose it reached roughly 95%. In the trial data the infection curves for the vaccine and placebo groups only began to separate around two weeks after the first shot.
Efficacy figures describe how much a vaccine cuts the rate of illness in a trial group compared with people given a placebo. A figure of 95% does not mean that 5% of vaccinated people will get sick. It means vaccinated volunteers developed symptomatic COVID-19 at about one twentieth of the rate of unvaccinated volunteers, over the period studied.
Comparisons with the flu shot were common at the time, and they need a little care. The US Centers for Disease Control and Prevention estimates that seasonal flu vaccine effectiveness varies widely from one season to the next, from about 19% in a poor year to around 60% in a good one. The early COVID-19 results were therefore strikingly high, but they came from a clinical trial against the original strain, which is not quite the same thing as real-world effectiveness measured over a flu season.
Infected before or after the shot?
There is a second, simpler explanation that may also apply. The incubation period of COVID-19, the time from infection to the first symptoms, can stretch to about 14 days, and is often around five. Someone who catches the virus a few days before vaccination, or on the day itself, will go on to develop the illness regardless of the vaccine, because the immune response is far behind the virus.
Both Pfizer and Dr. Ramers pointed this out. Given that Matthew was working on a COVID-19 unit in the run-up to Christmas, during one of the worst surges of the pandemic in Southern California, an infection picked up just before or just after the injection is entirely plausible. Nothing about his case suggests the vaccine failed.
Myths the case helped spread
"The vaccine gave him COVID-19"
It could not. The Pfizer-BioNTech vaccine contains messenger RNA instructions for making the coronavirus spike protein, not the virus itself. It cannot cause an infection. A sore arm, tiredness or a short fever after vaccination are signs of the immune system reacting, and a positive test means a real infection with the virus from somewhere else.
"If you can still get sick, the vaccine is useless"
No vaccine prevents every infection. The most important goal of the COVID-19 vaccines was always to reduce serious illness and death, and the full two-dose course in the trials cut symptomatic disease dramatically. A breakthrough case shortly after a first dose says nothing about how well the completed course works.
"One shot is enough"
For the original schedule, a single dose left people only partly protected. That is why health officials kept urging those recently vaccinated to continue taking precautions until their course was complete and a couple of weeks had passed.
The UK's decision to stretch the dose gap
The story broke just as the United Kingdom changed its own plans. On 30 December 2020, faced with a fast-spreading variant and limited supplies, UK health authorities decided to prioritise giving as many people as possible a first dose, pushing the second dose back to up to 12 weeks rather than three. Around the same day, the country was reporting more than 50,000 new cases and close to 1,000 deaths daily, and most of England was under tight restrictions.
The move was controversial, because Pfizer's trial had tested a 21-day interval. Later evidence, including a World Health Organization note that a longer gap can strengthen the immune response, eased many of those worries. The debate itself underlined the same point as the nurse's case: one dose gives partial, delayed protection, and timing matters.
What to take away
- Protection from a vaccine builds over days and weeks, not hours.
- An infection soon after a first dose is expected in a small number of people, especially those with heavy exposure.
- Symptoms within a few days of a shot may come from an infection caught before it.
- Completing the recommended course, and following current local guidance on boosters, gives the best protection. Anyone unsure about their own situation should talk to a doctor or pharmacist.
Matthew's case became a viral headline, but read carefully it is a textbook illustration of how vaccines work, and why the days just after a first shot are not yet the safe zone.
Sources: 10News San Diego: ER nurse tests positive eight days after vaccine; Wikipedia: Pfizer-BioNTech COVID-19 vaccine (trial efficacy data); CDC: Flu vaccine effectiveness studies; Pfizer public statement on the case (December 2020).

COMMENTS